List view / Grid view

Cell and Gene Therapy Catapult



Developing micro QC for ATMPs

3 January 2024 | By

In this Q&A, Natalie Saunders, Interim Head of Quality Control at CGT Catapult, delves into the advancements and challenges in microbiological QC for cell and gene therapies. She discusses rapid sterility testing methods, regulatory frameworks, and the impact of automation and digitalisation on quality control.